14
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Plasmodium vivax relapses after 5 days of primaquine treatment, in some industrial complexes of India

&
Pages 655-659 | Received 30 Apr 2001, Accepted 02 Aug 2001, Published online: 15 Nov 2016

REFERENCES

  • Adak, T., Sharma, V. P. & Orlov, V. S. (1998). Studies on the Plasmodium vivax relapse pattern in Delhi, India. American Journal of Tropical Medicine and Hygiene, 59, 175–179.
  • Baird, J. K., Leksana, B., Masbar, S., Fryauff, D. J., Sutanihardja, M. A., Wignall, S. F. S. & Hoffman, S. L. (1997). Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. American Journal of Tropical Medicine and Hygiene, 56, 621–626.
  • Basavaraj, H. R. (1960). Observations on the treatment of 678 malaria cases with primaquine in an area free from malaria transmission in Mysore state of India. Indian. Journal of Malariology, 14, 269–281.
  • Collins, W. E. & Jeffery, G. M. (1996). Primaquine resistance in Plasmodium vivax. American Journal of Tropical Medicine and Hygiene, 55, 243–249.
  • Dua, V. K., Sharma, S. K. & Sharma, V. P. (1991). Bioenvironmental control of malaria at the Indian Drugs and Pharmaceuticals Ltd. Rishikesh (U.P.). Indian Journal of Malariology, 28, 227–235.
  • Dua, V. K., Kar, P. K. & Sharma, V. P. (1996). Chloroquine resistant Plasmodium vivax malaria in India. Tropical Medicine and International Health, 1, 816–819.
  • Dua, V. K., Sharma, S. K., Srivastava, A. & Sharma, V. P. (1997). Bioenvironmental control of industrial malaria at Bharat Heavy Electricals Ltd., Hardwar. India. Results of a nine-year study (1987–95). Journal of the American Mosquito Control Association, 13, 278–285.
  • Dua, V. K., Nanda, N., Gupta, N. C., Kar, P. K., Sharma, V. P. & Subbarao, S. K. (2000). Investigation of malaria prevalence at the National Thermal Power Corporation, Shaktinagar, District Sonbhadra (Uttar Pradesh), India. Southeast Asian Journal of Tropical Medicine and Public Health, 31, 818–824.
  • Gogtay, N., Garg, N., Kadam, V., Kamtekar, K. & Kshirsagar, N. A. (1998). A 5-day primaquine regimen as anti-relapse therapy for Plasmodium vivax. Transactions of the Royal Society of Tropical Medicine and Hygiene, 92, 341.
  • Gogtay, N. J., Desai, S., Kamtekar, K. D., Kadam, V. S., Dalvi, S. S. & Kshirsagar, N. A. (1999). Efficacies of 5- and 14-day primaquine regimens in the prevention of relapses in Plasmodium vivax infections. Annals of Tropical Medicine and Parasitology, 93, 809–812.
  • Rowland, M. & Durrani, N. (1999). Randomized controlled trials of 5- and 14-days primaquine therapy against relapses of vivax malaria in an Afghan refugee settlement in Pakistan. Transactions of the Royal Society of Tropical Medicine and Hygiene, 93, 641–643.
  • Roy, R. G., Shanmugham, C. A. K., Chakrapani, K. V. & Ganeshan, A. V. (1979). Results of 5-day course of radical treatment of Plasmodium vivax in six districts of Tamil Nadu. Indian Journal of Medical Research, 69, 939–943.
  • Sharma, R. C., Gautam, A. S., Orlov, V. & Sharma, V. P. (1990). Relapse pattern of Plasmodium vivax in Kheda District, Gujarat. Indian Journal of Malariology, 27, 95–99.
  • Sharma, V. P. (1996). Re-emergence of malaria in India. Indian Journal of Medical Research, 103, 26–45.
  • Singh, J. (1956). J.S.B. stain—a review. Indian Journal of Malariology, 10, 117.
  • Singh, N., Mishra, A. K. & Sharma, V. P. (1990). Radical treatment of vivax malaria in Madhya Pradesh, India. Indian Journal of Malariology, 27, 55–56.
  • Sinha, S., Dua, V. K. & Sharma, V. P. (1989a). Efficacy of 5-day radical treatment of primaquine in Plasmodium vivax cases at the BHEL industrial complex, Hardwar (U.P.). Indian Journal of Malariology, 26, 83–86.
  • Sinha, S., Dua, V. K. & Sharma, V. P. (1989b). Malaria relapses and chloroquine resistance at the BHEL industrial complex, Hardwar. Transactions of the Royal Society of Tropical Medicine and Hygiene, 83, 606.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.